Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial

Saved in:
Bibliographic Details
Main Authors: Sandmann, Thomas (Author) , Wick, Wolfgang (Author)
Format: Article (Journal)
Language:English
Published: 1 September 2015
In: Journal of clinical oncology
Year: 2015, Volume: 33, Issue: 25, Pages: 2735-2746
ISSN:1527-7755
DOI:10.1200/JCO.2015.61.5005
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2015.61.5005
Get full text
Author Notes:Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais
Description
Item Description:Gesehen am 19.12.2016
Physical Description:Online Resource
ISSN:1527-7755
DOI:10.1200/JCO.2015.61.5005